Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance P and insulinlike growth factor I for neurotrophic keratitis

Archives of Ophthalmology

Volumn 122, Issue 11, 2004, Pages 1722-1723

  Brown, Sandra M ^a   Khanani, Arshad M ^b   Stetson, Cloyce L ^b   Reid, Ted W ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; HYALURONIC ACID; SOMATOMEDIN C; SUBSTANCE P;

ARTICLE; BLISTER; CASE REPORT; CHILD; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; KERATITIS; NERVE PARALYSIS; NEUROTROPHIC KERATITIS; PRIORITY JOURNAL; TRIGEMINAL NERVE DISEASE;

ACCIDENTS, TRAFFIC; ADMINISTRATION, TOPICAL; CHILD, PRESCHOOL; CORNEA; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KERATITIS; OPHTHALMIC SOLUTIONS; SKIN DISEASES, VESICULOBULLOUS; SUBSTANCE P; TRIGEMINAL NERVE DISEASES;

EID: 8144223700     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.11.1722     Document Type: Article

References (6)

1. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol. 1997;115:926-927.
2. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor 1. Lancet. 1998;351:1783-1784.
3. Lee CH, Whiteman AL, Murphy CJ, et al. Substance P, insulinlike growth factor 1, and surface healing. Arch Ophthalmol. 2002;120:215-217.
4. Lyon CC, Mughal MZ, Muston HL. Herpetic trigeminal trophic syndrome in an infant. J R Soc Med. 2001;94:135-137.
5. Streilein JW, Alard P, Niizeki H. Neural influences on induction of contact hypersensitivity. Ann N Y Acad Sci. 1999;885:196-208.
6. Gutwald J, Goebeler M, Sorg C. Neuropeptides enhance irritant and allergic contact dermatitis. J Invest Dermatol. 1991;96:695-698.